Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Colostrum | 4 | 2020 | 87 | 1.14 | Why? |
| Food Hypersensitivity | 3 | 2018 | 397 | 1.03 | Why? |
| Familial Hypophosphatemic Rickets | 1 | 2021 | 8 | 0.92 | Why? |
| Lactoferrin | 2 | 2021 | 208 | 0.90 | Why? |
| Anaphylaxis | 4 | 2018 | 940 | 0.85 | Why? |
| Transforming Growth Factor beta2 | 2 | 2018 | 13 | 0.81 | Why? |
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2019 | 6 | 0.81 | Why? |
| Paternity | 1 | 2019 | 7 | 0.80 | Why? |
| Milk, Human | 6 | 2020 | 956 | 0.79 | Why? |
| Triptorelin Pamoate | 1 | 2018 | 7 | 0.77 | Why? |
| Asthma, Exercise-Induced | 1 | 2018 | 10 | 0.75 | Why? |
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2018 | 37 | 0.74 | Why? |
| Gonadotropin-Releasing Hormone | 1 | 2018 | 53 | 0.73 | Why? |
| Puberty, Precocious | 1 | 2018 | 33 | 0.73 | Why? |
| Desensitization, Immunologic | 3 | 2018 | 574 | 0.68 | Why? |
| Contraindications | 1 | 2017 | 96 | 0.68 | Why? |
| Myocytes, Smooth Muscle | 1 | 2018 | 127 | 0.66 | Why? |
| Omalizumab | 1 | 2019 | 158 | 0.66 | Why? |
| Breast Feeding | 5 | 2020 | 1585 | 0.65 | Why? |
| Common Variable Immunodeficiency | 1 | 2019 | 195 | 0.64 | Why? |
| Lactation | 2 | 2018 | 361 | 0.63 | Why? |
| Respiratory Hypersensitivity | 1 | 2017 | 103 | 0.62 | Why? |
| Immunoglobulin E | 2 | 2018 | 557 | 0.60 | Why? |
| Fertility | 1 | 2019 | 367 | 0.56 | Why? |
| Reproductive Techniques, Assisted | 1 | 2019 | 400 | 0.53 | Why? |
| Asthma | 5 | 2018 | 4383 | 0.51 | Why? |
| Microbiota | 3 | 2018 | 1240 | 0.45 | Why? |
| Migraine Disorders | 1 | 2018 | 530 | 0.44 | Why? |
| Dietary Supplements | 2 | 2021 | 2251 | 0.43 | Why? |
| Polymorphism, Genetic | 1 | 2018 | 1074 | 0.43 | Why? |
| Perioperative Period | 1 | 2011 | 276 | 0.40 | Why? |
| Drug Hypersensitivity | 2 | 2018 | 401 | 0.40 | Why? |
| Chromosomes, Human, Pair 13 | 2 | 2019 | 8 | 0.40 | Why? |
| Allergens | 4 | 2018 | 728 | 0.39 | Why? |
| Membrane Proteins | 1 | 2019 | 1733 | 0.36 | Why? |
| Respiratory System | 2 | 2018 | 3213 | 0.36 | Why? |
| Kartagener Syndrome | 2 | 2018 | 19 | 0.35 | Why? |
| Infant, Newborn | 6 | 2020 | 23105 | 0.33 | Why? |
| Immunoglobulin A | 1 | 2018 | 3567 | 0.32 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 1261 | 0.31 | Why? |
| Dermatitis, Atopic | 3 | 2019 | 714 | 0.30 | Why? |
| Pediatrics | 2 | 2018 | 2969 | 0.29 | Why? |
| Child | 20 | 2022 | 70012 | 0.26 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.26 | Why? |
| Vitamin D | 4 | 2021 | 2904 | 0.25 | Why? |
| Hypersensitivity, Immediate | 2 | 2017 | 134 | 0.25 | Why? |
| Comparative Genomic Hybridization | 2 | 2019 | 33 | 0.24 | Why? |
| Developing Countries | 1 | 2018 | 4283 | 0.24 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.23 | Why? |
| Mites | 1 | 2001 | 26 | 0.23 | Why? |
| Hepatocyte Growth Factor | 2 | 2018 | 71 | 0.22 | Why? |
| Vaccines | 2 | 2018 | 3692 | 0.22 | Why? |
| Ambulatory Care | 1 | 2018 | 4947 | 0.22 | Why? |
| Siblings | 2 | 2019 | 226 | 0.21 | Why? |
| Risk | 3 | 2018 | 5288 | 0.21 | Why? |
| Chromosome Aberrations | 1 | 2019 | 54 | 0.20 | Why? |
| Chromosome Disorders | 1 | 2019 | 24 | 0.20 | Why? |
| Juglans | 1 | 2018 | 4 | 0.19 | Why? |
| Corylus | 1 | 2018 | 7 | 0.19 | Why? |
| Burundi | 1 | 2018 | 60 | 0.19 | Why? |
| Hormones | 1 | 2019 | 66 | 0.19 | Why? |
| Baths | 1 | 2019 | 62 | 0.19 | Why? |
| Gonadal Dysgenesis, 46,XY | 1 | 2018 | 2 | 0.19 | Why? |
| Proteobacteria | 1 | 2018 | 36 | 0.19 | Why? |
| Child, Preschool | 7 | 2021 | 36283 | 0.19 | Why? |
| Epilepsy, Generalized | 1 | 2018 | 16 | 0.19 | Why? |
| Bronchial Hyperreactivity | 1 | 2018 | 38 | 0.19 | Why? |
| Infant Food | 1 | 2018 | 39 | 0.18 | Why? |
| Synbiotics | 1 | 2017 | 15 | 0.18 | Why? |
| Chromosome Deletion | 1 | 2018 | 62 | 0.18 | Why? |
| Arachis | 1 | 2018 | 58 | 0.18 | Why? |
| Hedgehog Proteins | 1 | 2018 | 39 | 0.18 | Why? |
| Milk Hypersensitivity | 1 | 2017 | 24 | 0.18 | Why? |
| Microbial Consortia | 1 | 2017 | 20 | 0.18 | Why? |
| Homocysteine | 1 | 2018 | 83 | 0.18 | Why? |
| Conjunctivitis, Allergic | 1 | 2019 | 94 | 0.17 | Why? |
| Pedigree | 1 | 2019 | 502 | 0.17 | Why? |
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2017 | 33 | 0.17 | Why? |
| Hypersensitivity | 2 | 2018 | 1137 | 0.17 | Why? |
| Infant Formula | 1 | 2017 | 64 | 0.17 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.17 | Why? |
| Parents | 2 | 2021 | 2758 | 0.16 | Why? |
| Parent-Child Relations | 1 | 2021 | 384 | 0.16 | Why? |
| Bacteria | 2 | 2018 | 1897 | 0.16 | Why? |
| Allergy and Immunology | 1 | 2020 | 240 | 0.16 | Why? |
| Delayed-Action Preparations | 1 | 2018 | 291 | 0.16 | Why? |
| Airway Remodeling | 1 | 2017 | 111 | 0.16 | Why? |
| Matrix Metalloproteinases | 1 | 2017 | 131 | 0.16 | Why? |
| Transforming Growth Factor beta | 1 | 2018 | 363 | 0.15 | Why? |
| Polyneuropathies | 1 | 2018 | 157 | 0.15 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.15 | Why? |
| Breast | 1 | 2018 | 290 | 0.15 | Why? |
| Italy | 9 | 2021 | 38444 | 0.15 | Why? |
| Medical History Taking | 1 | 2017 | 350 | 0.14 | Why? |
| Vitamin D Deficiency | 2 | 2019 | 1782 | 0.14 | Why? |
| Developed Countries | 1 | 2018 | 500 | 0.14 | Why? |
| Stress Disorders, Post-Traumatic | 2 | 2021 | 2963 | 0.14 | Why? |
| Food | 1 | 2017 | 316 | 0.14 | Why? |
| Humans | 41 | 2022 | 930598 | 0.13 | Why? |
| Child Development | 1 | 2018 | 352 | 0.13 | Why? |
| Amino Acids | 1 | 2017 | 552 | 0.13 | Why? |
| Eczema | 1 | 2017 | 227 | 0.13 | Why? |
| Adolescent | 10 | 2022 | 86841 | 0.13 | Why? |
| Human bocavirus | 1 | 2014 | 142 | 0.13 | Why? |
| Zinc | 1 | 2021 | 817 | 0.13 | Why? |
| DNA | 1 | 2019 | 778 | 0.12 | Why? |
| Probiotics | 1 | 2021 | 694 | 0.12 | Why? |
| Insulin Resistance | 1 | 2018 | 669 | 0.12 | Why? |
| Diet, Mediterranean | 1 | 2017 | 351 | 0.12 | Why? |
| Vaccination | 2 | 2018 | 19050 | 0.12 | Why? |
| Consensus | 4 | 2020 | 6345 | 0.12 | Why? |
| Dermatologic Agents | 1 | 2018 | 489 | 0.12 | Why? |
| Lung | 2 | 2018 | 31049 | 0.12 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.12 | Why? |
| Intellectual Disability | 1 | 2018 | 391 | 0.12 | Why? |
| Postpartum Period | 1 | 2018 | 936 | 0.11 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.11 | Why? |
| Sex Distribution | 1 | 2018 | 2083 | 0.11 | Why? |
| Metapneumovirus | 1 | 2014 | 465 | 0.11 | Why? |
| Environmental Exposure | 1 | 2001 | 1558 | 0.10 | Why? |
| Sinusitis | 1 | 2018 | 649 | 0.10 | Why? |
| Female | 17 | 2022 | 380317 | 0.10 | Why? |
| Pregnancy | 5 | 2019 | 23879 | 0.10 | Why? |
| Respiratory Syncytial Viruses | 1 | 2014 | 612 | 0.10 | Why? |
| Health Priorities | 1 | 2018 | 959 | 0.09 | Why? |
| Immunization | 1 | 2018 | 2019 | 0.09 | Why? |
| Vitamins | 1 | 2018 | 1208 | 0.09 | Why? |
| Societies, Medical | 3 | 2020 | 6907 | 0.09 | Why? |
| Age Distribution | 1 | 2018 | 3567 | 0.09 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2018 | 1234 | 0.09 | Why? |
| Infant | 7 | 2019 | 30274 | 0.09 | Why? |
| Anxiety Disorders | 1 | 2021 | 2290 | 0.09 | Why? |
| Rhinovirus | 1 | 2014 | 979 | 0.09 | Why? |
| Clinical Decision-Making | 2 | 2020 | 3755 | 0.08 | Why? |
| Swimming | 1 | 2007 | 57 | 0.08 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.08 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.08 | Why? |
| Feeding Behavior | 1 | 2018 | 1909 | 0.07 | Why? |
| Orthomyxoviridae | 1 | 2014 | 1168 | 0.07 | Why? |
| Research | 1 | 2018 | 2115 | 0.07 | Why? |
| Dyspnea | 1 | 2018 | 3847 | 0.07 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.07 | Why? |
| Adult | 8 | 2021 | 244371 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2017 | 1961 | 0.07 | Why? |
| Male | 13 | 2021 | 367725 | 0.07 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.06 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| Residual Volume | 1 | 2001 | 45 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.06 | Why? |
| Sputum | 2 | 2017 | 1720 | 0.05 | Why? |
| Cytogenetic Analysis | 1 | 2019 | 21 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.05 | Why? |
| Chromosomes | 1 | 2019 | 17 | 0.05 | Why? |
| Respiratory Function Tests | 2 | 2018 | 1755 | 0.05 | Why? |
| Severity of Illness Index | 2 | 2018 | 48226 | 0.05 | Why? |
| Bronchi | 1 | 2007 | 1048 | 0.05 | Why? |
| Mosaicism | 1 | 2019 | 44 | 0.05 | Why? |
| Olfaction Disorders | 1 | 2018 | 3704 | 0.05 | Why? |
| Chromosomes, Human, Pair 12 | 1 | 2019 | 84 | 0.05 | Why? |
| Treatment Outcome | 4 | 2019 | 51732 | 0.05 | Why? |
| Rho Guanine Nucleotide Exchange Factors | 1 | 2018 | 10 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Skin Care | 1 | 2019 | 49 | 0.05 | Why? |
| SOXB1 Transcription Factors | 1 | 2018 | 20 | 0.05 | Why? |
| Cross-Sectional Studies | 4 | 2021 | 53120 | 0.05 | Why? |
| Egg Proteins | 1 | 2018 | 14 | 0.05 | Why? |
| Eubacterium | 1 | 2017 | 5 | 0.05 | Why? |
| Weaning | 1 | 2018 | 46 | 0.05 | Why? |
| Clostridium | 1 | 2017 | 33 | 0.05 | Why? |
| Practice Guidelines as Topic | 3 | 2018 | 15421 | 0.05 | Why? |
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 350 | 0.05 | Why? |
| Ophthalmic Solutions | 1 | 2019 | 136 | 0.04 | Why? |
| Genetic Markers | 1 | 2019 | 318 | 0.04 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Child, Hospitalized | 1 | 2022 | 556 | 0.04 | Why? |
| Exercise | 1 | 2018 | 6771 | 0.04 | Why? |
| Administration, Cutaneous | 1 | 2018 | 229 | 0.04 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.04 | Why? |
| Oligosaccharides | 1 | 2017 | 69 | 0.04 | Why? |
| Mental Disorders | 1 | 2020 | 6742 | 0.04 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.04 | Why? |
| Milk | 1 | 2017 | 158 | 0.04 | Why? |
| Retrospective Studies | 2 | 2018 | 105322 | 0.04 | Why? |
| Nitric Oxide | 2 | 2018 | 769 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Interleukin-13 | 1 | 2017 | 204 | 0.04 | Why? |
| Mouth Mucosa | 1 | 2019 | 323 | 0.04 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2017 | 211 | 0.04 | Why? |
| Tacrolimus | 1 | 2019 | 435 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2018 | 605 | 0.04 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.04 | Why? |
| Paranasal Sinuses | 1 | 2018 | 217 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.04 | Why? |
| Interleukin-2 | 1 | 2017 | 443 | 0.04 | Why? |
| Adaptation, Physiological | 1 | 2018 | 359 | 0.04 | Why? |
| Animals | 3 | 2018 | 78931 | 0.04 | Why? |
| Cyclosporine | 1 | 2019 | 449 | 0.04 | Why? |
| Eosinophils | 1 | 2001 | 848 | 0.04 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.04 | Why? |
| Injections, Subcutaneous | 1 | 2017 | 647 | 0.03 | Why? |
| Face | 1 | 2018 | 301 | 0.03 | Why? |
| Breath Tests | 1 | 2018 | 338 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.03 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2018 | 10649 | 0.03 | Why? |
| Biodiversity | 1 | 2017 | 546 | 0.03 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.03 | Why? |
| Micronutrients | 1 | 2017 | 310 | 0.03 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.03 | Why? |
| Cattle | 1 | 2017 | 1336 | 0.03 | Why? |
| Russia | 1 | 2017 | 989 | 0.03 | Why? |
| Gestational Age | 1 | 2017 | 1488 | 0.03 | Why? |
| Metabolomics | 1 | 2018 | 921 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2022 | 17020 | 0.03 | Why? |
| Self Care | 1 | 2019 | 918 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2017 | 1289 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2017 | 1887 | 0.02 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.02 | Why? |
| Prospective Studies | 3 | 2022 | 43301 | 0.02 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.02 | Why? |
| Molecular Targeted Therapy | 1 | 2018 | 1579 | 0.02 | Why? |
| Smell | 1 | 2018 | 1851 | 0.02 | Why? |
| Delivery, Obstetric | 1 | 2017 | 1292 | 0.02 | Why? |
| Middle Aged | 4 | 2019 | 270681 | 0.02 | Why? |
| Chlorine | 1 | 2007 | 55 | 0.02 | Why? |
| Leukotriene B4 | 1 | 2007 | 46 | 0.02 | Why? |
| Cesarean Section | 1 | 2017 | 2089 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Health Personnel | 1 | 2017 | 29646 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Drug Design | 1 | 2018 | 2627 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.01 | Why? |
| Antigens, Viral | 1 | 2018 | 6298 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Tomography, X-Ray Computed | 2 | 2018 | 25144 | 0.01 | Why? |
| Risk Factors | 2 | 2022 | 71621 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| United Kingdom | 1 | 2017 | 18046 | 0.01 | Why? |
| Depression | 1 | 2021 | 14116 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Anxiety | 1 | 2021 | 17311 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Aged | 1 | 2022 | 215776 | 0.00 | Why? |